Elevance Health's EBIT per Share for the
three
months ended in Mar. 2026 was MXN217.72.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN628.57.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Elevance Health's EBIT per Share or its related term are showing as below:
MEX:ELV's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Plans industry.
Industry Median: -6.2 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Elevance Health's EBIT for the
three
months ended in Mar. 2026 was MXN47,985 Mil.
Elevance Health (MEX:ELV) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Elevance Health EBIT per Share Related Terms
Elevance Health EBIT per Share Historical Data
* Premium members only.
The historical data trend for Elevance Health's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN628.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (MEX:ELV) has a EBIT per Share of MXN628.57 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Elevance Health and its competitors. According to the industry distribution chart, Elevance Health ranks #999999 out of 13 companies in the Healthcare Plans industry.
Is Elevance Health's EBIT per Share too high?
Elevance Health's current EBIT per Share is MXN628.57. Based on the distribution chart, Elevance Health ranks #999999 out of 13 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Elevance Health has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's EBIT per Share compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #999999 out of 13 companies for EBIT per Share. This places Elevance Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Plans company?
A good EBIT per Share depends on the Healthcare Plans industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Elevance Health and its competitors. Elevance Health's current EBIT per Share is MXN628.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,845.39, compared to a current price of MXN7,144.06 — trading 19.2% below its estimated fair value. The current EBIT per Share is MXN628.57. Elevance Health's overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current EBIT per Share is MXN628.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (MEX:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of MXN7,144.06 is trading 19.2% below its estimated GF Value™ of MXN8,845.39.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for MEX:ELV:
EBIT per Share: MXN628.57
GF Value™: MXN8,845.39 vs. price of MXN7,144.06 (19.2% below fair value)
No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
75GF Score
Get the complete analysis for MEX:ELV
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELV has been successfully added to your 
